Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication dateMar 2022
Number of pages1
Publication statusPublished - Mar 2022

    Research areas

  • 64cu-dotatate, neuroendocrine neoplasm, pet imaging, ssr imaging

ID: 326289939